Drug details

Lithium Carbonate Tablets (lithium carbonate)

type of

Lithium Carbonate Extended-Release Tablets are antimanic agents indicated in the treatment of manic episodes of Bipolar Disorder. Lithium Carbonate Extended-Release Tablets are also indicated as a maintenance treatment for individuals with a diagnosis of Bipolar Disorder. Maintenance therapy reduces the frequency of manic episodes and diminishes the intensity of those episodes that may occur. Lithium Carbonate Extended-Release Tablets are available in generic form.

The drug is often used to treat Bipolar disorder .

This drug may have the following side effects:
  • vomiting,
  • diarrhea,
  • weakness,
  • drowsiness,
  • increased urination, 
  • blurred vision, and
  • lack of coordination,
  • hand tremors,
  • mild thirst,
  • muscular weakness,
  • giddiness,
  • ringing in the ears.
The following drugs are related to Lithium Carbonate Tablets, either as a replacement or used together:
  • Abilify (aripiprazole)
  • Abilify Maintena (aripiprazole extended-release injectable suspension)
  • Tegretol (carbamazepine)
  • Carbatrol (carbamazepine extended-release)
  • Equetro (carbamazepine xr)
  • Depacon (valproic acid)
  • Depakote ER (divalproex sodium)
  • Depakote Sprinkle Capsules (divalproex sodium sprinkle capsules)
  • Latuda (lurasidone hcl tablets for oral administration)
  • Zyprexa (olanzapine)
  • Zyprexa Relprevv (olanzapine extended release injectable suspension)
  • Seroquel (quetiapine fumarate)
  • Seroquel XR (quetiapine fumarate extended-release tablets)
  • Risperdal (risperidone)
  • Risperdal Consta (risperidone)